» Articles » PMID: 36833251

A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Feb 25
PMID 36833251
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudohypoparathyroidism (PHP) is a heterogeneous orphan disease characterized by multihormonal resistance and several phenotypic features. In some cases, PHP is caused by a mutation in the that encodes the alpha subunit of the G protein, one of the key transmitters of intracellular signals. A correlation between the genotype and phenotype of patients with mutations has not yet been described. This often makes diagnosis, drug prescription, and timely diagnosis difficult. Information about GNAS functioning and the impact of specific mutations on the clinical course of the disease is limited. Establishing of the pathogenicity by newly identified mutations will expand the understanding of this gene functioning in the cAMP signaling pathway and may become the basis for personalized treatment. This paper provides a clinical description of a patient with the Ia PHP phenotype caused by a previously unknown mutation in (NC_000020.11(NM_000516.7)): c.719-29_719-13delinsACCAAAGAGAGCAAAGCCAAG in the heterozygous state. Verification of the pathogenicity of the detected mutation is also described.

Citing Articles

Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.

Sippelli F, Briuglia S, Ferraloro C, Capra A, Agolini E, Abbate T BMC Pediatr. 2024; 24(1):271.

PMID: 38664677 PMC: 11044326. DOI: 10.1186/s12887-024-04761-8.


Pseudohypoparathyroidism versus signaling disorder: A case report.

Imam A SAGE Open Med Case Rep. 2023; 11:2050313X231205776.

PMID: 37860280 PMC: 10583501. DOI: 10.1177/2050313X231205776.

References
1.
Mantovani G, Elli F . Multiple hormone resistance and alterations of G-protein-coupled receptors signaling. Best Pract Res Clin Endocrinol Metab. 2018; 32(2):141-154. DOI: 10.1016/j.beem.2018.01.002. View

2.
Chang G, Li Q, Li N, Li G, Li J, Ding Y . Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children. BMC Endocr Disord. 2022; 22(1):70. PMC: 8928694. DOI: 10.1186/s12902-022-00941-8. View

3.
Klenke S, Siffert W, Frey U . A novel aspect of GNAS imprinting: higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol Cell Endocrinol. 2011; 341(1-2):63-70. DOI: 10.1016/j.mce.2011.05.032. View

4.
Chen M, Shrestha Y, Podyma B, Cui Z, Naglieri B, Sun H . Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations. J Clin Invest. 2016; 127(2):500-510. PMC: 5272175. DOI: 10.1172/JCI88622. View

5.
Pereda A, Elli F, Thiele S, de Sanctis L, Rothenbuhler A, Hanna P . Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients. Eur J Endocrinol. 2020; 184(2):311-320. DOI: 10.1530/EJE-20-0625. View